Hospital
Public Hospital District No 4 King County Washington
Public Hospital District No 4 King County Washington was paid $9.23M by Medicaid between Jan 2018 and Nov 2024, across 86 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoPUBLIC HOSPITAL DISTRICT NO 4 KING COUNTY WASHINGTON
SNOQUALMIE, WA 98065
SNOQUALMIE, WA 98065
33aNPI1902846546assigned 06/08/2006
33bProvider typeCritical Access Hospital
28Total paid$9.23M
24GClaims58,587
24DCodes billed86
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Washington
Rank by total paid#15 of 30
Median peer was paid$9.10M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,730 | $1.05M | |
| 2019 | 5,010 | $950K | |
| 2020 | 6,692 | $813K | |
| 2021 | 11,960 | $1.26M | |
| 2022 | 9,737 | $1.54M | |
| 2023 | 9,691 | $1.93M | |
| 2024incomplete | 6,767 | $1.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 3,878 | 3,573 | $2.70M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 1,195 | 1,090 | $1.57M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 505 | 433 | $989K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.2% | 1,557 | 1,469 | $667K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 5.6% | 2,503 | 928 | $514K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.0% | 1,472 | 1,336 | $274K |
| 80053 | Comprehensive metabolic panel | 2.4% | 4,997 | 4,619 | $224K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.1% | 2,322 | 2,149 | $194K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 4,962 | 4,504 | $187K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 1,282 | 544 | $175K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 638 | 592 | $148K |
| 71045 | Radiologic examination, chest; single view | 1.5% | 496 | 448 | $139K |
74 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 1.5% | 1,936 | $138K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 927 | $116K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,237 | $82K |
| 80061 | Lipid panel | <1% | 1,330 | $77K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 693 | $64K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,615 | $64K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 797 | $57K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 770 | $47K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 518 | $46K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 119 | $45K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,478 | $42K |
| 97035 | <1% | 407 | $42K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 784 | $41K |
| 83690 | <1% | 1,082 | $40K | |
| 83605 | <1% | 354 | $40K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 922 | $35K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 27 | $34K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 329 | $31K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 284 | $31K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 972 | $28K |
| 82728 | <1% | 494 | $25K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 148 | $25K |
| 84703 | <1% | 638 | $24K | |
| 84484 | <1% | 524 | $24K | |
| 87400 | <1% | 385 | $20K | |
| 90836 | <1% | 880 | $19K | |
| 84439 | <1% | 450 | $16K | |
| 84481 | <1% | 259 | $16K | |
| 81001 | <1% | 1,277 | $15K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,900 | $15K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 168 | $15K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 120 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 155 | $9K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 67 | $9K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 67 | $9K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 356 | $8K |
| 81003 | <1% | 605 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 229 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 25 | $7K |
| 83550 | <1% | 208 | $7K | |
| 36592 | <1% | 79 | $6K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 27 | $6K |
| 83540 | <1% | 207 | $5K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 509 | $5K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 817 | $4K |
| 82607 | <1% | 53 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 442 | $3K |
| 83880 | <1% | 15 | $3K | |
| 80306 | <1% | 33 | $3K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 27 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 71 | $2K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 908 | $2K |
| 82550 | <1% | 33 | $2K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $1K |
| 80305 | <1% | 40 | $1K | |
| 97014 | <1% | 30 | $1K | |
| J3490 | Unclassified drugs | <1% | 282 | $1K |
| 84403 | <1% | 14 | $1K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 89 | $1K |
| 87807 | <1% | 15 | $1K | |
| 80320 | <1% | 118 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 12 | $902.46 |
| 86803 | <1% | 13 | $884.90 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $867.76 |
| 82553 | <1% | 15 | $772.30 | |
| 86140 | <1% | 40 | $755.36 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 24 | $720.14 |
| 86769 | <1% | 18 | $640.74 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 201 | $489.50 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 33 | $68.26 |
| 90688 | <1% | 12 | $33.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $28.43 |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDONOVAN, BARBI (MSS & PE MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Public Hospital District No 4 King County Washington | Snoqualmie, WA | $1.92M |
| Public Hospital District No 4 King County Washington | Snoqualmie, WA | $968K |
| Public Hospital District No 4, King County Wa | Snoqualmie, WA | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.